This study aimed to evaluate the association between radiologically defined sarcopenia, assessed as low SMI on PET-based imaging, and pCR in patients with HER2-positive and TNBC undergoing neoadjuvant therapy. This evidence concerns the gene ERBB2 and sarcopenia.